395 related articles for article (PubMed ID: 19675453)
21. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
[TBL] [Abstract][Full Text] [Related]
22. Relationship between columnar cell changes and low-grade carcinoma in situ of the breast--a cytogenetic study.
Go EM; Tsang JY; Ni YB; Yu AM; Mendoza P; Chan SK; Lam CC; Lui PC; Tan PH; Tse GM
Hum Pathol; 2012 Nov; 43(11):1924-31. PubMed ID: 22542249
[TBL] [Abstract][Full Text] [Related]
23. Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
Hoque A; Sneige N; Sahin AA; Menter DG; Bacus JW; Hortobagyi GN; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):587-90. PubMed ID: 12050101
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal aberrations as detected by array comparative genomic hybridization in early low-grade intraepithelial neoplasias of the breast.
Stacher E; Boldt V; Leibl S; Halbwedl I; Popper HH; Ullmann R; Tavassoli FA; Moinfar F
Histopathology; 2011 Sep; 59(3):549-55. PubMed ID: 21906127
[TBL] [Abstract][Full Text] [Related]
25. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
[TBL] [Abstract][Full Text] [Related]
26. [Early loss of heterozygosity on chromosome arm 16q in flat epithelial atypia of the breast. Detection by microsatellite analyses].
Schmidt H; Dahrenmöller C; Agelepoulos K; Hungermann D; Böcker W
Pathologe; 2008 Nov; 29 Suppl 2():328-32. PubMed ID: 18807038
[TBL] [Abstract][Full Text] [Related]
27. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
28. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers.
Tang P; Wang X; Schiffhauer L; Wang J; Bourne P; Yang Q; Quinn A; Hajdu SI
Ann Clin Lab Sci; 2006; 36(1):16-22. PubMed ID: 16501232
[TBL] [Abstract][Full Text] [Related]
29. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
30. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions.
Kunju LP; Ding Y; Kleer CG
Pathol Int; 2008 Oct; 58(10):620-5. PubMed ID: 18801081
[TBL] [Abstract][Full Text] [Related]
31. The "Rosen Triad": tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions.
Brandt SM; Young GQ; Hoda SA
Adv Anat Pathol; 2008 May; 15(3):140-6. PubMed ID: 18434766
[TBL] [Abstract][Full Text] [Related]
32. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
33. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
[TBL] [Abstract][Full Text] [Related]
34. Expression patterns of beta-catenin in in situ and invasive breast cancer.
Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M
Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489
[TBL] [Abstract][Full Text] [Related]
35. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
[TBL] [Abstract][Full Text] [Related]
36. Do breast columnar cell lesions with atypia need to be excised?
Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
[TBL] [Abstract][Full Text] [Related]
37. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Vincent-Salomon A; Lucchesi C; Gruel N; Raynal V; Pierron G; Goudefroye R; Reyal F; Radvanyi F; Salmon R; Thiery JP; Sastre-Garau X; Sigal-Zafrani B; Fourquet A; Delattre O;
Clin Cancer Res; 2008 Apr; 14(7):1956-65. PubMed ID: 18381933
[TBL] [Abstract][Full Text] [Related]
38. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.
Abdel-Fatah TM; Powe DG; Hodi Z; Reis-Filho JS; Lee AH; Ellis IO
Am J Surg Pathol; 2008 Apr; 32(4):513-23. PubMed ID: 18223478
[TBL] [Abstract][Full Text] [Related]
39. Primary mammary small-cell carcinoma: a molecular analysis of 2 cases.
Hoang MP; Maitra A; Gazdar AF; Albores-Saavedra J
Hum Pathol; 2001 Jul; 32(7):753-7. PubMed ID: 11486176
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay.
Yu Q; Niu Y; Yu Y; Ding X; Shi Y
Breast Cancer Res Treat; 2009 Apr; 114(3):433-40. PubMed ID: 18425676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
